Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Synthesis of Novel Benzofuran and Related Benzimidazole Derivatives for Evaluation of In Vitro Anti-HIV-1, Anticancer and Antimicrobial Activities

  • Rida, Samia M. (Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Alexandria) ;
  • El-Hawash, Soad A.M. (Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Alexandria) ;
  • Fahmy, Hesham T.Y. (Department of Pharmaceutical Sciences, College of Pharmacy, South Dakota State University Brookings) ;
  • Hazzaa, Aly A. (Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Alexandria) ;
  • El-Meligy, Mostafa M.M. (Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Alexandria)
  • Published : 2006.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Previously, we synthesized and evaluated several benzofuran derivatives containing heterocyclic ring substituents linked to the benzofuran nucleus at C-2 by a two- to four-atom spacer as potential anti-HIV-1, anticancer and antimicrobial agents. Among these derivatives, NSC 725612 and NSC 725716 exhibited interesting anti-HIV-1 activity. To further investigate the structure-activity relationship, we synthesized several new benzofuran derivatives derived from 2-acetylbenzofuran (2, 3a-c) and 2-bromoacetylbenzofuran (6; 7a,b; 8a,b). The compounds were designed to comprise the heterocyclic substituents directly linked to the benzofuran nucleus at C-2. Moreover, various related benzimidazoles derived from 2-acetylbenzimidazole and from 2-cyanomethylbenzimidazole (12a,b; 13a,b; 15; 16a,b) were also prepared as isosteres. The synthesized compounds were preliminarily evaluated for their in vitro anti-HIV-1, anticancer and antimicrobial activity. Compounds 2, 3a, 3b, and 12b showed weak anti-HIV-1 activity. Compound 6 exhibited mild activity against S. aureus, while compound 15 had mild activity towards S. aureus and C. albicans. However, no significant anticancer activity was observed with any of the tested compounds. From these results, we conclude that the presence of the spacer between the heterocyclic substituent and the benzofuran nucleus may be essential for the biological activity.

Keywords

References

  1. Badawey, E.A. and Kappe, T., Benzimidazole condensed ring systems. XI. Synthesis of some substituted cycloalkyl pyrido[1,2-a]benzimidazoles with anticipated antineoplastic activity. Eur. J. Med. Chem., 34, 663-667 (1999) https://doi.org/10.1016/S0223-5234(00)80036-7
  2. Buckheit, R. W. Jr, Hollingshead, M. G., Germany-Decker, J, White, E. L., McMahon, J. B., Allen, L. B., Ross, L. J., Decker, W. D., Westbrook, L., and Shannon, W. M., Thiazolobenzimidazole: Biological and biochemical anti-retroviral activity of a new non-nucleoside reverse transcriptase inhibitor. Antiviral Res., 21, 247-265 (1993) https://doi.org/10.1016/0166-3542(93)90031-D
  3. Conte, J. E. and Barriere, S. L., Manual of Antibiotics and Infectious Diseases, 1st Ed. Lea and Febiger, U.S.A., 135 (1988)
  4. Copeland, R. A. and Day, A. R., The preparation and reactions of 2-benzimidazolylecarboxylic acid and 2-benzimidazolacetic acid, J. Am. Chem. Soc., 65, 1072-1075 (1943) https://doi.org/10.1021/ja01246a019
  5. Demirayak, S., Abu Mohsen, U., and Cagri Karaburun, A., Synthesis and anticancer and anti-HIV testing of some pyrazino[1,2-a]benzimidazole derivatives. Eur. J. Med. Chem., 37, 255-260 (2002) https://doi.org/10.1016/S0223-5234(01)01313-7
  6. El-Hawash, S. A., Badawey, E. A., and Kappe, T., Benzimidazole condensed ring system. XII. Synthesis and anticancer evaluation of certain pyrido[1,2-a]benzimidazole derivatives. Pharmazie, 54, 341-346 (1999)
  7. Elliott, E. D., The preparation and properties of 2-vinylbenzofuran, J. Am. Chem. Soc., 73, 754 (1951) https://doi.org/10.1021/ja01146a075
  8. Ghabrial, S. S., Zaki, M. Y., and Eldin, S. M., Hydrazidoylhalides in heterocyclic synthesis of several new pyrazole[5,1-c]- 1,2,4-triazine,pyramidine and thiazole derivatives, Egypt J. Pharm. Sci., 37(1-6) 329-339 (1996)
  9. Grever, M., Schepartz, S., and Chabner, B., The National Cancer Institute Cancer Drug Discovery and Development Program Semin. Oncol., 19, 622-638 (1992)
  10. Hao, D., Rizzo, J. D., Stringer, S., Moore, R. V., Marty, J., Dexter, D. L., Mangold, G. L., Camden, J. B.,Von Hoff, D. D., and Weitman, S. D., Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642). Invest. New Drugs, 20, 261-270 (2002) https://doi.org/10.1023/A:1016253716438
  11. Hutchinson, S., Luetjens, H., and Scammells, P., A new synthesis of the benzofuran adenosine antagonist XH-14, Bioorg. Med. Chem. Lett. 7, 3081-3084 (1997) https://doi.org/10.1016/S0960-894X(97)10173-1
  12. Kempter, G., Sarodnick, G., Schaefer, H., and Fiebig, H. J., Spindler, Heterocycles from 2-bromoacetyl heterocycles J., Z. Chem., 8(9) 339-340 (1968), Through C. A., 70, 11630b (1969) https://doi.org/10.1002/zfch.19680080914
  13. Kovalenko, S. N., Vasil`ev, M. V., Sorokina, I. V., ChernyKh, V. P., Turov, A. V., and Rundnev, S. A., Recyclization of 2-imino- 2H-1-benzopyrans using nucleophilic reagents3. Reactions of 2-iminocoumarin-3-carboxamides with o-phenylenediamines and o-amino(thio)phenols, Chem. Heterocycl. Comp., 34, 1412-1415 (1999), Through C. A., 131, 257452p (1999) https://doi.org/10.1007/BF02317811
  14. Ozegowski, W. and Krebs, D., Amino acid antagonists IV. Attempted synthesis of [1-methyl-5-bis(b-chloroethyl)aminobenzimidazol- 2-yl]acetic acid, J. Prakt. Chem., 29(1-2), 18-25, Through C. A., 63, 8341g (1965) https://doi.org/10.1002/prac.19650290101
  15. Pieters, L, Van Dyck, S, Gao, M, Bai, R, Hamel, E., and Vlietinck A., Lemi inverted question markere G. Synthesis and biological evaluation of dihydrobenzofuran lignans and related compounds as potential antitumor agents that inhibit tubulin polymerization. J. Med. Chem., 42, 5475-5481 (1999) https://doi.org/10.1021/jm990251m
  16. Pinney, K., Pettit, G., Mocharla, V., Del, P., Majia, M., and Shirali, A., Benzo[b]thiophen derivatives, useful as antimitotic agents which inhibit tubulin polymerization and as antitumor agents, US Appl., 813, 018, 6 Mar. (1997) 85 pp (Eng.), C. A., 129, 245037c (1998)
  17. Reynold, J. E. F., Martindale The Extra Pharmacopeia, 30thed., Royal Pharmaceutical Society of Great Britain, Pharmaceutical Press, London (a) P 46, 54-55 (b) P 319, (c) P 544 (1993)
  18. Rida, S. M., El-Hawash, S. A., Fahmy, H. T., Hazza, A. A., Eland Meligy, M. M., Synthesis and in vitro Evaluation of some Novel Benzofuran Derivatives as Potential Anti-HIV-1, Anticancer and Antimicrobial Agents. Arch. Pharm. Res., 29, 16-25 (2006) https://doi.org/10.1007/BF02977463
  19. Scott, A. C., Laboratory Control of Antimicrobial Therapy. In: Colle, J. G., Duguid, J. P., Fraser, A. G., Marmion, B. P., Mackie and MacCartney Practical Medical Microbiology, Churchill Livingstone, 13th edition, 2, 161-181 (1989)
  20. Weislow, O. W., Kiser, R., Fine, D., Bader, J., Shoemaker, R. H., Boyd, M. R., New soluble-formazan assay for HIV-I cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity, J. Natl. Cancer Inst., 81, 577-586 (1989) https://doi.org/10.1093/jnci/81.8.577